Sibutramine/Meridia: Abbot labs voluntarily pulled sibutramine from the us market in 2010 because clinical trials showed increased risk of heart attack and stroke. Many other countries followed suit. It inhibits central reuptake of dopamine, norepinephrine, and serotonin -- serotonin mechanism may increase satiety; ne one may increase metabolic rate. Some generic forms may be available, but not by prescription.
Answered 12/9/2013
5.7k views
5 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question